Pipobroman is an oral chemotherapy drug used in the treatment of certain types of cancer. It is used in combination with other anti-cancer drugs to reduce the risk of leukemia or other blood-related cancers. It works by blocking the growth and spread of cancer cells in the body. Common side effects include nausea, vomiting, loss of appetite, mouth sores, hair loss, fatigue, and diarrhea.
Pipobroman is an anti-cancer medication used to treat specific blood cancers. Here's a breakdown of its key features:
- Type of drug: Antineoplastic agent (fights cancer)
- Mechanism of action: Likely acts as an alkylating agent, damaging cancer cell DNA and hindering their growth. The exact mechanism is still under investigation.
- Conditions it treats: Primarily used for Polycythemia Vera (increased red blood cell count) and Essential Thrombocythemia (increased platelet count)
- Availability: Marketed in France and Italy under trade names Vercite or Vercyte.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01A - Alkylating agents
L01AX Other alkylating agents
ATC Code
External Links
Pipobroman